---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-000972"
form_type: "8-K"
ticker: "ANIK"
cik: "0000898437"
company_name: "Anika Therapeutics, Inc."
filed_at: "2024-02-26T23:59:59+00:00"
generated_at: "2026-06-05T16:19:06.907367+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Director Jeffery S. Thompson to retire; John B. Henneman appointed Board Chair

## Summary
- Jeffery S. Thompson will retire from Anika's Board at the 2024 Annual Meeting after 13 years.
- John B. Henneman, III, an independent director since 2020, appointed Board Chair effective immediately.
- Thompson's retirement not due to any disagreement with the Company's operations, policies, or practices.
- Board will have seven directors after Thompson's departure; two Class I directors to be elected at Annual Meeting.

## SEC filing metadata
- accession: 0001171843-24-000972
- form_type: 8-K
- ticker: ANIK
- cik: 0000898437
- company_name: Anika Therapeutics, Inc.
- filed_at: 2024-02-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/898437/000117184324000972/0001171843-24-000972-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/898437/000117184324000972/f8k_022624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-000972
- JSON: https://secwatch.observer/filing/0001171843-24-000972.json
- Plain text: https://secwatch.observer/filing/0001171843-24-000972.txt

## Key facts
- Executive change
  John B. Henneman, III was appointed as Chair of the Board at Anika Therapeutics, Inc..
  - Action: appointed
  - Role: Chair of the Board
  source text: In connection with Mr. Thompson’s planned retirement, John B. Henneman, III, an independent director of the Company’s Board since 2020, has been appointed Chair of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/898437/000117184324000972/0001171843-24-000972-index.htm
- Executive change
  Jeffery S. Thompson departed as Director at Anika Therapeutics, Inc..
  - Action: retire
  - Role: Director
  source text: On February 24, 2024, Jeffery S. Thompson notified Anika Therapeutics, Inc. (the “Company”) of his intention to retire from the Board of Directors (the “Board”) after 13 years of dedicated service at the end of his current term.
  evidence_url: https://www.sec.gov/Archives/edgar/data/898437/000117184324000972/0001171843-24-000972-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.